Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$159.82 - $182.1 $264,022 - $300,829
1,652 New
1,652 $300,000
Q2 2023

Jul 17, 2023

BUY
$132.51 - $164.9 $158,349 - $197,055
1,195 Added 33.07%
4,809 $647,000
Q1 2023

Apr 18, 2023

BUY
$144.61 - $166.54 $53,650 - $61,786
371 Added 11.44%
3,614 $575,000
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $448,539 - $537,916
3,243 New
3,243 $524,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Retirement Guys Formula LLC Portfolio

Follow Retirement Guys Formula LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Guys Formula LLC, based on Form 13F filings with the SEC.

News

Stay updated on Retirement Guys Formula LLC with notifications on news.